Study of Systemic Impact of Trace Elements Release by Implantable Medical Devices. Identification of Biomarkers of Systemic Inflammation
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jean-Claude Alvarez, MD, PhD
Laboratoire de Pharmacologie-Toxicologie, Hôpital Raymond Poincaré, Garches
Principal Investigator - Thomas BAUER, MD, PhD
Orthopédie et traumatologie, Hôpital Ambroise Paré, Boulogne-Billancourt
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Service de Chirurgie Orthopédique, Hôpital Raymond Poincaré
Garches, Hauts-des-Seine, France
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 24 Jun 2019
- Primary completion
- 19 Mar 2021
- Completion
- 19 Mar 2021
- Last update posted
- 21 Apr 2022
- Registered enrollment
- 159
- Registry id
- NCT03812627
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.